Molecular docking studies of gloriosa superba for anti cancer and anti tuberculosis

Abstract

Gloriosa superba is a medicinal plant generally found in western parts of Tamilnadu and kerala in India.  Gloriosa superba having the medicinal property of anticancer, antibacterial, antifungal, anti Tuberculosis and mutagenic activities. In these studies, we are going to analysis the anti-cancer and anti-tuberculosis property of Gloriosa superba by using molecular docking studies. Cancer is a major cause of death and the number of new cases, as well as the number of individuals living with cancer, is expanding continuously. Cervical cancer is one of the most common cancers among women worldwide. Tuberculosis is a common and often deadly infectious disease caused by mycobacteria, usually Mycobacterium tuberculosis in humans. Tuberculosis usually attacks the lungs but can also affect other parts of the body. The phytochemicals of Gloriosa superba are analysed and optimized with the Arguslab to investigate the interactions between the target compounds and the amino acid residues of the E7 and DAHP. All the compound has shown binding pose between from – 3.25 to -7.95 and -7.95 into -11.40 out of ten compounds. Chrysophanic acid with E7 protein and Colchicine with DAHP protein show best ligand energy -9.52049 and -7.47679Kcal/mol with 1 and 3 hydrogen bond of distance is 2.3 and 2.2,2.9 and 3.2 respectively.